Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Prabu Siva Sankar"'
Autor:
Prabu Siva Sankar, Marimuthu Citartan, Aminah Ahmed Siti, Boris V. Skryabin, Timofey S. Rozhdestvensky, Goot Heah Khor, Thean Hock Tang
Publikováno v:
Iranian Journal of Microbiology, Vol 11, Iss 2 (2019)
Background and Objectives: Pfu DNA polymerase is an enzyme that exhibits the lowest error rate in the 3´ to 5´ exonuclease (proofreading) activity during DNA synthesis in Polymerase Chain Reactions (PCRs). This study was aimed to express and purify
Externí odkaz:
https://doaj.org/article/8c0f6334da53419cbf36a747f1cc7fec
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aminah Ahmed Siti, Thean-Hock Tang, Prabu Siva Sankar, Goot Heah Khor, Boris V. Skryabin, Timofey S. Rozhdestvensky, Marimuthu Citartan
Publikováno v:
Iranian Journal of Microbiology, Vol 11, Iss 2 (2019)
Background and Objectives: Pfu DNA polymerase is an enzyme that exhibits the lowest error rate in the 3´ to 5´ exonucle- ase (proofreading) activity during DNA synthesis in Polymerase Chain Reactions (PCRs). This study was aimed to express and puri
Autor:
Alan Khoo Soo-Beng, Kalaivani Muniandy, Venugopal Balakrishnan, Prabu Siva Sankar, Benedict Lian Shi Xiang, Nethia Mohana-Kumaran
Publikováno v:
Tropical Life Sciences Research. 27:125-130
Spheroids have been shown to recapitulate the tumour in vivo with properties such as the tumour microenvironment, concentration gradients, and tumour phenotype. As such, it can serve as a platform for determining the growth and invasion behaviour pat
Autor:
Prabu Siva Sankar, Alan Soo-Beng Khoo, Phang Su Ling, Nethia Mohana-Kumaran, Mohd Firdaus Che Mat, Susan Ling Ling Hoe, Kalaivani Muniandy, Benedict Lian Shi Xiang
Nasopharyngeal carcinoma (NPC) is a type of cancer endemic in Asia, including Malaysia, Southern China, Hong Kong and Taiwan. Treatment resistance, particularly in recurring cases, remains a challenge. Thus, studies to develop novel therapeutic agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1041b8553b85d431bcb4fff807f7aa
https://europepmc.org/articles/PMC5403637/
https://europepmc.org/articles/PMC5403637/